Table 2.
Clinical variables related to disease burden
| Entire population (n = 648) | Female (n = 231) | Male (n = 417) | p value | |
|---|---|---|---|---|
| Pt-GDA | 4.4 (2.2) | 4.7 (2.1) | 4.2 (2.2) | 0.0039 |
| Pain-VAS | 40.5 (24.1) | 45.7 (23.2) | 37.6 (24.1) | <0.0001 |
| BASDAI | 3.6 (2.2) | 4.2 (2.2) | 3.2 (2.1) | <0.0001 |
| BASFI | 3.1 (2.5) | 3.5 (2.4) | 2.9 (2.5) | 0.0034 |
| BASMI | 2.9 (2.6) | 2.6 (2.3) | 3.1 (2.8) | 0.0610 |
| EQ-5D | 0.63 (20.5) | 0.61 (19.6) | 0.64 (20.9) | 0.0710 |
Data are presented as mean (SD)
Pt-GDA global disease activity, VAS visual analog scale, BASDAI bath ankylosing spondylitis disease activity index, EQ-5D euroQol health status, BASFI bath ankylosing spondylitis functional index, BASMI bath ankylosing spondylitis metrology index